Pegase 03: A prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

Pierre Biron,M Durand,Henri Roché,T. Delozier,C. Battista,P. Fargeot,Dominique Spaeth,Thomas Bachelot,E Poiget,F Monnot,M L Tanguy,H. Cure

Pegase 03: A prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

2008

Pierre Biron
M Durand
Henri Roché
T. Delozier
C. Battista
P. Fargeot
Dominique Spaeth
Thomas Bachelot
E Poiget
F Monnot
M L Tanguy
H. Cure

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

Keywords:

Breast cancer
Immunology
Cancer
Breast disease
ThioTEPA
Medicine
Autologous stem-cell transplantation
Metastasis
Cyclophosphamide
Chemotherapy
Metastatic breast cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations